On October 28, Zhejiang Jinhua New Materials Co., Ltd. announced that, without affecting its fundraising investment plans and ensuring the safety of raised funds, the company will rationally utilize up to RMB530 million in idle raised funds for cash management. This move aims to improve capital efficiency, increase company profits, and safeguard the interests of all shareholders. Additionally, without hindering normal business operations, the company plans to deploy up to RMB800 million in idle own capital for cash management.
The company specializes in the R&D, production, and sales of ketoxime-based fine chemicals, including silane crosslinkers, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime. It is a domestic leader in silane crosslinkers and hydroxylamine salts.
Silane crosslinkers serve as key raw materials for producing silicone sealants and adhesives, with end products widely used in construction, energy, electronics, and new energy vehicles. These products are classified as critical materials under China’s strategic emerging industries. Hydroxylamine salts are primarily used in broad-spectrum, low-toxicity pesticides, antibacterial drugs, eco-friendly metal extractants, ion-exchange resins, and green dyes. Methoxyamine hydrochloride and acetaldehyde oxime also find applications in low-toxicity pesticide production.
The company emphasizes technological innovation and green development, pioneering a circular industrial chain for ketoxime-based products. Its green process boasts high atomic efficiency, safety, and minimal waste. Recognized for innovation, the company has received multiple awards, including the Zhejiang Provincial Science and Technology Progress Award (2021), the China Petroleum and Chemical Industry Federation’s Science and Technology Progress Award (2022), and the China Patent Excellence Award (2024).
Notable honors include National "Little Giant" Enterprise, National Green Factory, and Zhejiang Provincial Invisible Champion. The company has contributed to drafting national/industry standards such as GB/T 33074-2016 and HG/T 5093-2016. It operates key research institutes, including the Zhejiang Ketoxime Silicon New Materials Enterprise Research Institute and a provincial postdoctoral workstation.
With strong product quality and production capabilities, Jinhua has established partnerships with multinationals like Bayer and Brenntag, as well as listed firms such as Wanhua Chemical (600309.SH), Xinan Chemical (600596.SH), and Cynda Chemical (603086.SH). Its trade clients include Guibao Technology (300019.SZ), H.B. Fuller (FUL.N), and Oriental Yuhong (002271.SZ).
In 2024, the company reported revenue of RMB1.239 billion and net profit of RMB211 million.
Comments